JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.

Setting

Order Through VWR & Receive a FREE Sample

Support: [email protected]

Track Your Order

Home
Bioactive Compounds

Bioactive Compounds

A4489 TC-A 2317 hydrochloride

Target: Aurora Kinases

Summary: Aurora kinase A inhibitor,potent and selective

<39.29 mg/mL
A8244 Cycloheximide
60 Citation

Summary: protein biosynthesis inhibitor

≥14.05 mg/mL
A8247 Afatinib (BIBW2992)
2 Citation

Target: EGFR

Summary: Irreversible EGFR/HER2 inhibitor

≥24.3 mg/mL
A8250 LY 294002
67 Citation

Target: PI3K

Summary: Potent PI3K inhibitor
A8327 Verteporfin
10 Citation

Target: YAP

Summary: Photosensitizer used in photodynamic therapy

insoluble in EtOH; insoluble in H2O; ≥18.3 mg/mL
A8501 PHA-848125

Target: Cyclin-Dependent Kinases

Summary: CDK inhibitor,potent and ATP-competitive

≥23.05 mg/mL
A8645 Viomycin

Summary: Antibiotic of tuberactinomycin family

<66.14 mg/mL
A8804 AMG232
2 Citation

Target: p53-MDM2 interaction

Summary: p53-MDM2 inhibitor, novel

≥53.3 mg/mL
B3233 Z-LEHD-FMK
21 Citation

Target: Caspases

Summary: Irreversible Caspase-9 inhibitor.

insoluble in H2O; ≥107.4 mg/mL
B3248 Vanoxerine dihydrochloride
1 Citation

Summary: potent and selective DRI (Dopamine reuptake inhibitor)

insoluble in EtOH; ≥15.4 mg/mL